SCHEMBL2143786

SCHEMBL2143786

CN(Cc1ccco1)C(=O)c1ccc2cccnc2c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.50
▸ EGLN1 Q9GZT9 12/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ NPC1 O15118 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ TP53 P04637 2/20 0.45
▸ ALOX12 P18054 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ HTT P42858 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.44
▸ MITF O75030 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ KDM4C Q9H3R0 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ RIPK1 Q13546 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2143783 0.81 EGLN1 (0.60) ALDH1A1EGLN1LMNATP53HSP90AA1
SCHEMBL2143826 0.80 ALDH1A1 (0.60) ALDH1A1EGLN1HPGDHSD17B10
SCHEMBL2143809 0.80 EGLN1 (0.49) ALDH1A1EGLN1KDM4ELMNATP53
SCHEMBL16735589 0.79 HSP90AA1 (0.52) ALDH1A1KDM4EL3MBTL1LMNAMAPK1
SCHEMBL2143868 0.78 ALDH1A1 (0.57) ALDH1A1EGLN1L3MBTL1RAB9A
SCHEMBL2143905 0.78 ALDH1A1 (0.51) ALDH1A1EGLN1
SCHEMBL2143813 0.78 ALDH1A1 (0.51) ALDH1A1EGLN1HPGD
SCHEMBL2143802 0.78 EGLN1 (0.63) ALDH1A1EGLN1L3MBTL1NPC1LMNA
SCHEMBL2202703 0.78 EGLN1 (0.66) ALDH1A1EGLN1KDM4ENPC1LMNA
SCHEMBL2144042 0.77 ALDH1A1 (0.50) ALDH1A1EGLN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105384685-A New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA 2016-03-09 — — CN claimed
EP-2519505-B1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2015-05-27 — — EP claimed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 — — US claimed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 — — US claimed
EP-2345643-A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM S.A. (LU) 2011-07-20 — — EP claimed
CN-105384685-A New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA 2016-03-09 — — CN disclosed
EP-2519505-B1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2015-05-27 — — EP disclosed
EP-2519505-B1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2015-05-27 — — EP disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 — — US disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 — — US disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 — — US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 — — US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 — — US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 — — US disclosed
EP-2519505-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF Polichem SA (LU) 2012-11-07 — — EP disclosed
EP-2345643-A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM S.A. (LU) 2011-07-20 — — EP disclosed
WO-2011080264-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM S.A. (LU) 2011-07-07 — — WO disclosed
WO-2011080264-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM S.A. (LU) 2011-07-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF TUBA8, SUCLG1, TUBB8 ALDH1A1 931/4885EGLN1 777/4885KDM4E 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback